Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer-Response

Mario Sznol; Lieping Chen

doi:10.1158/1078-0432.CCR-13-2234

Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer-Response

Mario Sznol, Lieping Chen

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	5542
Number of pages	1
Journal	Clinical Cancer Research
Volume	19
Issue number	19
DOIs	https://doi.org/10.1158/1078-0432.CCR-13-2234
State	Published - Oct 1 2013
Externally published	Yes

ASJC Scopus subject areas

Cancer Research
Oncology

Access to Document

10.1158/1078-0432.CCR-13-2234

Cite this

@article{bed6ad708c04473fbd3f0722e670cec6,

title = "Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer-Response",

author = "Mario Sznol and Lieping Chen",

year = "2013",

month = oct,

day = "1",

doi = "10.1158/1078-0432.CCR-13-2234",

language = "English (US)",

volume = "19",

pages = "5542",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "19",

}

TY - JOUR

T1 - Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer-Response

AU - Sznol, Mario

AU - Chen, Lieping

PY - 2013/10/1

Y1 - 2013/10/1

UR - http://www.scopus.com/inward/record.url?scp=84886421073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886421073&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-13-2234

DO - 10.1158/1078-0432.CCR-13-2234

M3 - Article

C2 - 24048329

AN - SCOPUS:84886421073

SN - 1078-0432

VL - 19

SP - 5542

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 19

ER -

Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer-Response

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this